Related Experiment Video
Updated: Jan 29, 2026

Acute Myocardial Infarction in Rats
Published on: February 16, 2011
Functional genetic variants of the GATA4 gene promoter in acute myocardial infarction
Jing Chen1, Shuai Wang1, Shuchao Pang2
1Department of Medicine, Shandong University School of Medicine, Jinan, Shandong 250012, P.R. China.
Insights
Genetic variants in the GATA4 gene promoter may contribute to acute myocardial infarction (AMI) development. These DNA changes were found to increase GATA4 gene promoter activity, potentially impacting GATA4 levels and increasing AMI risk.
Area of Science:
- Cardiovascular Genetics
- Molecular Cardiology
Background:
- Coronary artery disease (CAD), including acute myocardial infarction (AMI), is a complex genetic disorder with largely unknown causes.
- A higher incidence of CAD in individuals with congenital heart disease suggests a role for cardiac developmental genes.
Purpose of the Study:
- To investigate the role of GATA binding protein 4 (GATA4) gene promoter variants in the development of AMI.
- To analyze GATA4 gene promoter activity in patients with AMI compared to healthy controls.
Main Methods:
- Analysis of the GATA4 gene promoter in 395 AMI patients and 397 healthy controls.
- Identification and characterization of DNA variants, including single-nucleotide polymorphisms.
- Electrophoretic mobility shift assay to assess transcription factor binding.
Main Results:
- Fourteen DNA variants were identified in the GATA4 promoter region.
- Three novel heterozygous variants (g.31806C>T, g.31900G>C, g.32241C>T) were found in three AMI patients.
- These variants significantly increased GATA4 gene promoter activity, and g.32241C>T affected transcription factor binding.
Conclusions:
- Novel DNA variants in the GATA4 gene promoter may contribute to AMI development.
- Altered GATA4 promoter activity and subsequent changes in GATA4 levels are implicated in AMI pathogenesis.
Abstract:
Coronary artery disease (CAD), including acute myocardial infarction (AMI), is a common complex disease; however, the genetic causes remain largely unknown. Recent epidemiological investigations indicated that the incidence of CAD in patients with congenital heart diseases is markedly higher than that observed in healthy controls. It was therefore hypothesized that the dysregulated expression of cardiac developmental genes may be involved in CAD development. GATA binding protein 4 (GATA4) serves essential roles in heart development and coronary vessel formation. In the present study, the GATA4 gene promoter was analyzed in patients with AMI (n=395) and in ethnically‑matched healthy controls (n=397). A total of 14 DNA variants were identified, including two single‑nucleotide polymorphisms. Three novel heterozygous DNA variants (g.31806C>T, g.31900G>C and g.32241C>T) were reported in three patients with AMI. These DNA variants significantly increased the activity of the GATA4 gene promoter. The electrophoretic mobility shift assay revealed that the DNA variant g.32241C>T influenced the binding ability of transcription factors. Taken together, the DNA variants may alter GATA4 gene promoter activity and affect GATA4 levels, thus contributing to AMI development.
Related Concept Videos
Mutation, Gene Flow, and Genetic Drift
Gene Flow
Histone Variants at the Centromere
The Eukaryotic Promoter Region
Organization of Genes
Genetics of Speciation

